Trump Administration pushes to make health care pricing more transparent

24 June 2019 - President Trump signed an executive order Monday on price transparency in health care that aims to ...

Read more →

Petition for national cancer agency gathers steam

25 June 2019 - A petition launched in support of a national cancer agency has so far gathered more than ...

Read more →

U.S. FDA accepts GSK’s application for Zejula (niraparib) in late stage ovarian cancer with priority review

24 June 2019 - GlaxoSmithKline plc today announced that Tesaro, an oncology-focused business acquired by GSK, submitted a supplemental new ...

Read more →

UK's MHRA renews EAMS scientific opinion for Santhera's idebenone in Duchenne muscular dystrophy

24 June 2019 - Santhera Pharmaceuticals announces that the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has renewed for ...

Read more →

Krystal Biotech receives regenerative medicine advanced therapy designation from FDA for KB103

24 June 2019 - RMAT designation granted to KB103 based on positive interim data from GEM-1 and GEM-2 study. ...

Read more →

Ipsen announces U.S. FDA approval for newly designed pre-filled syringe for Somatuline Depot (lanreotide)

24 June 2019 - New syringe designed to help enhance injection experience. ...

Read more →

Nabriva Therapeutics announces EMA validation of marketing authorisation application for lefamulin

24 June 2019 - Nabriva Therapeutics today announced that the EMA has determined that the company’s marketing authorisation application for the ...

Read more →

Lung cancer advocates feel disease is being ignored by Government

25 June 2019 - Advocates for lung cancer patients say the country's deadliest cancer is being ignored by health authorities. ...

Read more →

Incorporating patient preferences in non-inferiority trials

24 June 2019 - Non-inferiority trials imply a trade-off between a loss in efficacy of a standard treatment in exchange for ...

Read more →

The FDA erred in approving new women’s libido drug; don’t reward Palatin Technologies

24 June 2019 - The FDA made a mistake Friday by approving a new drug called Vyleesi for women with ...

Read more →

It’s Pioneer Institute vs. ICER: drug-pricing watchdog comes under fire for a ‘one-size-fits-all’ approach

24 June 2019 - An influential Boston-based watchdog group uses a “one-size-fits-all” approach to judge a fair price for prescription ...

Read more →

Forcing patients to switch to biosimilars puts them in uncharted waters

23 June 2019 - On May 27, the B.C. government announced a policy that will forcibly switch thousands of patients, ...

Read more →

England to fast-track tumour agnostic drugs like Vitrakvi – if the price is right

21 June 2019 - NHS England’s chief executive Simon Stevens was in Manchester this week at the NHS Confederation conference, ...

Read more →

Correvio resubmits Brinavess (vernakalant) new drug application to U.S. FDA for the treatment of patients with recent onset atrial fibrillation

24 June 2019 - Correvio Pharma today announced it has resubmitted a new drug application to the U.S. FDA seeking approval ...

Read more →

Veterans Agency to offer new depression drug, despite cost and safety concerns

21 June 2019 - Confronted by a rising rate of suicides in some groups of veterans., the Department of Veterans ...

Read more →